title: Management of fingolimod-associated macular edema.
authors.forename: Jeanie
authors.initials: J
authors.lastname: Chui
authors.forename: Geoffrey K
authors.initials: GK
authors.lastname: Herkes
authors.forename: Andrew
authors.initials: A
authors.lastname: Chang
mesh_terms: D000287:Administration, Topical; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D000068876:Fingolimod Hydrochloride; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007429:Intraocular Pressure; D020911:Ketorolac Tromethamine / Q000627:therapeutic use*; D008269:Macular Edema / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D011409:Propylene Glycols / Q000009:adverse effects*; D013110:Sphingosine / Q000009:adverse effects / Q000031:analogs & derivatives*; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome; D014792:Visual Acuity
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D020911:Ketorolac Tromethamine; D003907:Dexamethasone; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine